Showing results (161-170 of 499) with videos related to

Sort By:
Pageof 50
Plos One|April 13, 2011
HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodiesJi Wang, Pei Tong, Lu Lu, et al.
The Journal of Biological Chemistry|April 15, 2008
Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: interaction with gp41 fusion coreLu Lu, Yun Zhu, Jinghe Huang, et al.
Biochimica Et Biophysica Acta|August 8, 2012
HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domainLu Lu, Pei Tong, Xiaowen Yu, et al.
Frontiers in Microbiology|November 15, 2018
Topical Application of a Vitamin A Derivative and Its Combination With Non-ablative Fractional Laser Potentiates Cutaneous Influenza VaccinationPeiyu Li, Ji Wang, Miao Cao, et al.
Biochemical and Biophysical Research Communications|May 9, 2009
Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cellsLanying Du, Guangyu Zhao, Lin Li, et al.
Biochemical and Biophysical Research Communications|July 21, 2006
Identification of a D-amino acid decapeptide HIV-1 entry inhibitorCésar Boggiano, Shibo Jiang, Hong Lu, et al.
The Biochemical Journal|January 17, 2007
The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formationJing-He Huang, Heng-Wen Yang, Shuwen Liu, et al.
Journal of Medical Virology|July 6, 2022
Rock1 is a novel host dependency factor of human enterovirus A71: Implication as a drug targetXiaoyu Zhao, Cun Li, Man Chun Chiu, et al.
Cellular & Molecular Immunology|March 24, 2020
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccineWanbo Tai, Lei He, Xiujuan Zhang, et al.
Viruses|April 23, 2022
A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-LifeQianyu Duan, Shuai Xia, Fanke Jiao, et al.
Pageof 50